Evidence map›Paper›PMID 27843649›Full record

ArticleGenetics research international2016

Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells.

Hussein Sabit, Mariam B Samy, Osama A M Said, Mokhtar M El-Zawahri

Open access · hybridAbstract read
In one paragraph

Article in Genetics research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Long non-coding RNA LINC00261 sensitizes human colon cancer cells to cisplatin therapy.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2017
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hussein SabitCollege of Biotechnology, Misr University for Science and Technology, Giza, Egypt.ORCID 0000-0001-9021-8334
Mariam B SamyCollege of Biotechnology, Misr University for Science and Technology, Giza, Egypt.
Osama A M SaidCollege of Biotechnology, Misr University for Science and Technology, Giza, Egypt.
Mokhtar M El-ZawahriCollege of Biotechnology, Misr University for Science and Technology, Giza, Egypt; Center of Research and Development, Misr University for Science and Technology, Giza, Egypt.
Misr University for Science and Technology · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colon cancer is the third most commonly diagnosed cancer in the world, and it is the major cause of morbidity and mortality throughout the world. The present study aimed at treating colon cancer cell line (HCT116) with different chemotherapeutic drug/drug combinations (procaine, vorinostat "SAHA," sodium phenylbutyrate, erlotinib, and carboplatin). Two different final concentrations were applied: 3

Identifiers

PMID27843649
PMCPMC5098101
OpenAlexW2532529214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.